JENOMED: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
JENOMED
Largest movements
- Stocks and contracts +€144,385
up €144,385 (+87.8%), from €164,483 to €308,868
- Cash +€21,652
up €21,652 (+6,890%), from €314 to €21,967
mainly Short-term financial debts (+€260,000) and Net result for the year (+€38,883)
- Short-term financial debts +€260,000
new in 2025: €260,000
- Other debts -€137,234
down €137,234 (-93.2%), from €147,268 to €10,034
- Profit (loss) carried forward +€38,883
up €38,883, from -€8,923 to €29,960
- Advances received -€15,000
no longer reported in 2025 (was €15,000)
- Tax, wage and social debts +€12,122
new in 2025: €12,122
- Gross operating margin +€60,166
up €60,166, from -€2,397 to €57,769
- Taxes +€12,122
new in 2025: €12,122
- Financial charges +€4,664
up €4,664 (+642%), from €726 to €5,390
- Other operating charges +€938
up €938 (+214%), from €437 to €1,375
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €164,797 | €330,835 | +€166,037 | +101% |
| Current assets | 29/58 | €164,797 | €330,835 | +€166,037 | +101% |
| Stocks and contracts in progress | 3 | €164,483 | €308,868 | +€144,385 | +87.8% |
| Stocks | 30/36 | €164,483 | €308,868 | +€144,385 | +87.8% |
| Cash at bank and in hand | 54/58 | €314 | €21,967 | +€21,652 | +6,890% |
| Total equity and liabilities | 10/49 | €164,797 | €330,835 | +€166,037 | +101% |
| Equity | 10/15 | €1,077 | €39,960 | +€38,883 | +3,610% |
| Contributions | 10/11 | €10,000 | €10,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€8,923 | €29,960 | +€38,883 | |
| Amounts payable | 17/49 | €163,720 | €290,875 | +€127,155 | +77.7% |
| Amounts payable within one year | 42/48 | €163,720 | €287,992 | +€124,271 | +75.9% |
| Financial debts | 43 | - | €260,000 | +€260,000 | |
| Credit institutions | 430/8 | - | €260,000 | +€260,000 | |
| Trade debts | 44 | €1,452 | €5,836 | +€4,384 | +302% |
| Suppliers | 440/4 | €1,452 | €5,836 | +€4,384 | +302% |
| Advances received on contracts in progress | 46 | €15,000 | - | -€15,000 | |
| Taxes, remuneration and social security | 45 | - | €12,122 | +€12,122 | |
| Taxes | 450/3 | - | €12,122 | +€12,122 | |
| Other amounts payable | 47/48 | €147,268 | €10,034 | -€137,234 | -93.2% |
| Accrued charges and deferred income | 492/3 | - | €2,883 | +€2,883 | |
| Other operating charges | 640/8 | €437 | €1,375 | +€938 | +214% |
| Gross operating margin | 9900 | -€2,397 | €57,769 | +€60,166 | |
| Operating profit (loss) | 9901 | -€2,834 | €56,394 | +€59,229 | |
| Financial charges | 65/66B | €726 | €5,390 | +€4,664 | +642% |
| Recurring financial charges | 65 | €726 | €5,390 | +€4,664 | +642% |
| Profit (loss) for the period before taxes | 9903 | -€3,560 | €51,005 | +€54,565 | |
| Income taxes | 67/77 | - | €12,122 | +€12,122 | |
| Profit (loss) for the period | 9904 | -€3,560 | €38,883 | +€42,443 | |
| Profit (loss) for the period to be appropriated | 9905 | -€3,560 | €38,883 | +€42,443 |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 15 October 2026 via checked.be.